Patents by Inventor Peter Hölig

Peter Hölig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Masking and subsequently visualising ESR signals using the combination of two materials
    Patent number: 11666668
    Abstract: A body has multiple phases, which have different electron spin resonance spectra that do not result from the simple combination of the ESR spectra of each individual phase.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: June 6, 2023
    Assignee: Evonik Operations GmbH
    Inventors: Norbert Windhab, Andreas Karau, Peter Hölig, Benedikt Hartwig, Julia Lyubina
  • MASKING AND SUBSEQUENTLY VISUALISING ESR SIGNALS USING THE COMBINATION OF TWO MATERIALS
    Publication number: 20210164927
    Abstract: A body has multiple phases, which have different electron spin resonance spectra that do not result from the simple combination of the ESR spectra of each individual phase.
    Type: Application
    Filed: November 23, 2018
    Publication date: June 3, 2021
    Applicant: Evonik Operations GmbH
    Inventors: Norbert WINDHAB, Andreas Karau, Peter Hölig, Benedikt Hartwig, Julia Lyubina
  • Delivery system for sustained release of a calcium-channel blocking agent
    Patent number: 9060986
    Abstract: A delivery system for sustained release of a calcium-channel blocking agent is adapted for introduction in the cerebrospinal fluid of a subject. The delivery system comprises a solid dispersion product of a calcium-channel blocking agent in a mixture of a (i) first poly(lactide-co-glycolide) having a molecular weight distribution centered around a first number average molecular weight Mn1 and a (ii) second poly(lactide-co-glycolide) having a molecular weight distribution centered around a second number average molecular weight Mn2, wherein Mn1 is in the range of from 2000 to 3000 g/mol and the ratio of Mn1/Mn2 is from 1.8 to 3.5. The delivery system is deposited in the vicinity of or adjacent to a blood vessel showing vasospasm or suspected of developing vasospasm.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: June 23, 2015
    Assignee: BDS Pharma GmbH
    Inventors: Jorg Breitenbach, Bernd Liepold, Didier R. Lefebvre, Steffen Bossmann, Benedikt Steitz, Peter Hölig
  • Solid compositions
    Patent number: 8686026
    Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 1, 2014
    Assignee: AbbVie Inc.
    Inventors: Bernd Liepold, Tina Jung, Peter Hölig, Rudolf Schroeder, Nancy E. Sever, Justin S. Lafountaine, Brent D. Sinclair, Yi Gao, Jianwei Wu
  • Solid Compositions
    Publication number: 20120258909
    Abstract: The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
    Type: Application
    Filed: June 9, 2011
    Publication date: October 11, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Bernd Liepold, Tina Jung, Peter Hölig, Rudolf Schroeder, Nancy E. Sever, Justin S. Lafountaine, Brent D. Sinclair, Yi Gao, Jianwei Wu
  • DELIVERY SYSTEM FOR SUSTAINED RELEASE OF A CALCIUM-CHANNEL BLOCKING AGENT
    Publication number: 20120252851
    Abstract: A delivery system for sustained release of a calcium-channel blocking agent is adapted for introduction in the cerebrospinal fluid of a subject. The delivery system comprises a solid dispersion product of a calcium-channel blocking agent in a mixture of a (i) first poly(lactide-co-glycolide) having a molecular weight distribution centered around a first number average molecular weight Mn1 and a (ii) second poly(lactide-co-glycolide) having a molecular weight distribution centered around a second number average molecular weight Mn2, wherein Mn1 is in the range of from 2000 to 3000 g/mol and the ratio of Mn1/Mn2 is from 1.8 to 3.5. The delivery system is deposited in the vicinity of or adjacent to a blood vessel showing vasospasm or suspected of developing vasospasm.
    Type: Application
    Filed: October 5, 2010
    Publication date: October 4, 2012
    Inventors: Jorg Breitenbach, Bernd Liepold, Didier R. Lefebvre, Steffen Bossmann, Benedikt Steitz, Peter Hölig